Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

Company Overview - Orchestra BioMed Holdings, Inc. is a biomedical innovation company focused on accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies [3] - The company's lead product candidate is atrioventricular interval modulation (AVIM) therapy, also known as BackBeat Cardiac Neuromodulation Therapy (CNT™), aimed at treating hypertension, a significant global health risk [3] - Orchestra BioMed is also developing the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) for treating atherosclerotic artery disease, which is the leading cause of mortality worldwide [3] Strategic Partnerships - Orchestra BioMed has a strategic collaboration with Medtronic for the development and commercialization of AVIM therapy for hypertension in pacemaker-indicated patients [3] - The company has partnered with Terumo, a global leader in medical technology, for the development and commercialization of Virtue SAB for artery disease treatment [3] Upcoming Events - Company management will present and be available for one-on-one meetings at the Piper Sandler 36th Annual Healthcare Conference in New York from December 3-5, 2024 [1] - The presentation will take place on December 4, 2024, at 3:00 PM EST in a fireside chat format, with a webcast available for viewing [2]